Growth factor expression in ophthalmic pterygia and normal conjunctiva

International Journal of Molecular Medicine

Volumn 25, Issue 4, 2010, Pages 513-516

  Detorakis, Efstathios T ^a   Zaravinos, Apostolos ^b   Spandidos, Demetrios A ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Growth factors; Pterygium; qRT PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; RNA EXTRACTION;

ADULT; AGED; AGED, 80 AND OVER; CONJUNCTIVA; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PTERYGIUM; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77749289255     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000371     Document Type: Article

References (22)

1. Hilgers J: Pterygium: its incidence, heredity and etiology. Am J Opthalmol 50: 635-644, 1960.
2. Coroneo MT: Pterygium as an indicator of ultraviolet insulation: a hypothesis. Br J Ophthalmol 77: 734-739, 1993.
3. Gans L: Surgical Treatment of Pterygium. In: Focal Points. 0 no. 12. American Academy of Ophthalmology, San Francisco, 1996.
4. Kaimbo K: Surgical treatment of pterygium: 42 cases of excision. J Fr Ophtalmol 11: 335-338, 1988.
5. Detorakis ET, Drakonaki EE and Spandidos DA: Molecular genetic alterations and viral presence in ophthalmic pterygium (Review). Int J Mol Med 6: 35-41, 2000.
6. Di Girolamo N, Chui J, Coroneo MT and Wakefield D: Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 23: 195-228, 2004.
7. Detorakis ET, Sourvinos G, Tsamparlakis J and Spandidos DA: Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol 82: 1324-1328, 1998.
8. Zaravinos A, Bizakis J, Soufla G, Sourvinos G and Spandidos DA: Mutations and differential expression of the ras family genes in human nasal polyposis. Int J Oncol 31: 1051-1059, 2007.
9. Soulitzis N, Karyotis I, Delakas D and Spandidos DA: Expression analysis of peptide growth factors VEGFA, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol 29: 305-314, 2006.
10. Zaravinos A, Soufla G, Bizakis J and Spandidos DA: Expression analysis of VEGFA, FGF2, TGFß1, EGF and IGF1 in human nasal polyposis. Oncol Rep 19: 385-391, 2008.
11. Di Girolamo N, Coroneo MT and Wakefield D: UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci 44: 4705-4714, 2003.
12. Kria L, Ohira A and Amemiya T: Growth factors in cultured pterygium fibrobroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 236: 702-708, 1998.
13. Nugent MA and Iozzo RV: Fibroblast growth factor-2. Int J Biochem Cell Biol 32: 115-120, 2000.
14. Ley RD, Miska KB and Kusewitt DF: Photoreactivation of ultraviolet radiation-induced basic fibrobroblast growth factor (bFGF) and the role of bFGF in corneal lesion formation in Monodelphis domestica. Environ Mol Mutagen 38: 175-179, 2001.
15. Blaudschun R, Sunderkotter C, Brenneisen P, Hinrichs R, Peters T, Schneider L, Razi-Wolf Z, Hunzelmann N and Scharffetter-Kochanek K: Vascular endothelial growth factor causally contributes to the angiogenic response upon ultraviolet B irradiation in vivo. Br J Dermatol 146: 581-587, 2002.
16. Ma DH, Tsai RJ, Chu WK, Kao CH and Chen JK: Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest Ophthalmol Vis Sci 40: 1822-1828, 1999.
17. Lee JH, An HT, Chung JH, Kim KH, Eun HC and Cho KH: Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes. Photodermatol Photoimmunol Photomed 18: 253-261, 2002.
18. Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M and Bar-Dayan Y: Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 25: 17-22, 2002.
19. Hosseini H, Nejabat M and Khalili MR: Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia. Med Hypotheses 69: 925-927, 2007.
20. Bahar I, Kaiserman I, McAllum P, Rootman D and Slomovic A: Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. Curr Eye Res 33: 23-28, 2008.
21. Daher IN and Yeh ET: Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med 5: 797-805, 2008.
22. Emerson MV and Lauer AK: Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. Bio Drugs 21: 245-257, 2007.